AbCellera Biologics is announcing a new $700-million project today that will add research and development capacity to the manufacturing plant that has been in the works since 2020.
Opvee is similar to naloxone, the life-saving drug that has been used for decades to quickly counter overdoses of heroin, fentanyl and prescription painkillers.
The reality is, however, less than 15% of clinical research will ever make it into practice. Even when evidence is adopted into practice, this process can take as long as 17 years.